Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

UCB Pharma Limited
208 Bath Road, Slough, Berkshire, SL1 3WE
Telephone: +44 (0)1753 534 655
Medical Information Direct Line: +44 (0)1753 447 690
Medical Information e-mail: Medicalinformationuk@ucb.com
Customer Care direct line: +44 (0) 1773 510123

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 15/09/2005
SPC Ethanolamine Oleate Injection BP (UCB Pharma Ltd)


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Ethanolamine Oleate Injection (monoethanolamine oleate). Solution for injection.


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Oleic acid 4.23% w/v

Ethanolamine 0.910% w/v

For excipients see 6.1.


Go to top of the page
3. PHARMACEUTICAL FORM

Solution for injection.

5 ml neutral glass ampoule containing a clear solution.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

The injection is recommended for use as a sclerosing agent in the treatment of small, uncomplicated varicose veins in the lower extremities.


Go to top of the page
4.2 Posology and method of administration

Ethanolamine Oleate is administered by slow intravenous injection.

Adults Including The Elderly

The product is used only as a sclerosant and injected directly into the varicose vein. A dose of 2 to 5ml, divided between 3 or 4 sites, administered by slow injection into empty isolated segments of vein.

Children

The product is not recommended for use in children.


Go to top of the page
4.3 Contraindications

Inability to walk, acute phlebitis, oral contraceptive use, obese legs, known hypersensitivity to Ethanolamine Oleate or benzyl alcohol. Superficial thrombophlebitis and deep vein thrombosis in the region of the varicose veins. Marked arterial, cardiac or renal disease. Uncontrolled metabolic disorders such as diabetes mellitus. Patients with local or systemic infections.


Go to top of the page
4.4 Special warnings and precautions for use

Care should be taken to ensure that the injection does not leak into perivenous tissue which could cause sloughing, ulceration and in severe cases, necrosis.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

Safety during pregnancy has not been established. Use in pregnancy is not recommended.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

Burning, cramping sensation, urticaria. Allergic reactions and anaphylaxis have been reported following use of sclerosing agents.


Go to top of the page
4.9 Overdose

Acute nephrotoxicity has been reported in two patients given 15-20ml of a solution containing 5% Ethanolamine with 2% Benzl Alcohol.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

ATC Code: C05B B 01; sclerosing agent for local injection.

Ethanolamine Oleate is an irritant. An injection of Ethanolamine Oleate into a vein irritates the intimal endothelium resulting in the formation of a thrombus. The thrombus occludes the vein and fibrous tissue develops resulting in a permanent obliteration of the vein.


Go to top of the page
5.2 Pharmacokinetic properties

Ethanolamine Oleate is a locally acting agent. Absorption from the site of administration is not anticipated as its mode of action is to cause a permanent obstruction in the vein.


Go to top of the page
5.3 Preclinical safety data

None.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Benzyl alcohol

Water for Injection


Go to top of the page
6.2 Incompatibilities

Not applicable.


Go to top of the page
6.3 Shelf life

36 months.


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C. Keep the ampoule in the outer carton.


Go to top of the page
6.5 Nature and contents of container

5 ml Neutral Glass (Type 1) Ampoules.


Go to top of the page
6.6 Special precautions for disposal and other handling

The product is used only as a sclerosant and injected directly into the varicose vein.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

UCB Pharma Limited

208 Bath Road

Slough

Berkshire

SL1 3WE

UK


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 0039/5671R


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

27 March 1987 / 26 May 1994 / 27 May 1999


Go to top of the page
10. DATE OF REVISION OF THE TEXT

June 2005



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/4957/SPC/


Active Ingredients/Generics

 
  oleic acid bp
  ethanolamine bp